Search for: "Teva Pharmaceuticals"
Results 341 - 360
of 1,430
Sorted by Relevance
|
Sort by Date
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
11 Feb 2019, 12:15 pm
Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc. [read post]
13 Oct 2014, 9:01 am
Wednesday, the Supreme Court will hold one hour of oral argument on a high-stakes legal battle between a brand-name drug company and a group of companies making generic drugs – Teva Pharmaceuticals USA v. [read post]
15 Apr 2019, 6:09 am
Teva Pharmaceuticals USA Inc.: Allergan & SRMT Cert Petition Questions presented: Whether the Federal Circuit erred in this case, as it did in Acorda Therapeutics, Inc. v. [read post]
24 Aug 2012, 3:00 pm
.'s patent for its chemotherapy treatment Alimta, rejecting a challenge from generic drug makers Teva Parenteral Medicines Inc., Barr Laboratories Inc. and APP Pharmaceuticals Inc. [read post]
26 Jun 2015, 7:44 am
Law360.com provides insight into the background of the dispute in an article (subscription required for full access) that begins, "Drug purchasers challenging a no-authorized-generic settlement between GlaxoSmithKline PLC and Teva Pharmaceutical Industries ltd. told the Third Circuit on Friday that the U.S. [read post]
12 Oct 2018, 7:50 am
Teva Pharmaceuticals, blocking patent arguments have arisen in the Federal Circuit primarily in the pharmaceutical patent context, and until now have largely been limited to undermining evidence of commercial success. [read post]
30 Sep 2013, 4:50 am
Mark Lemley's Firm Files DJ Against Myriad in Northern California ----- Promise Not to Infringe Insufficient in ANDA Litigation ----- Licensing Deals Stall in Pharmaceutical Sector in First Half of 2013 ----- Mylan Settles with FTC over Agila Acquisition from Strides ----- Amgen and ShanghaiTech University Announce China R&D Center ----- Forest Laboratories sues over SAVELLA® generics ----- Teva Pharmaceutical scores patent cictory over Mylan on AZILECT® -----… [read post]
12 Jan 2017, 11:11 am
There is no pharmaceutical company that better reflects the challenges of trying to master both these product markets than the Israeli-based company, Teva Pharmaceutical Industries Ltd. [read post]
14 Jun 2010, 4:30 am
In the wake of two headline-grabbing hits to its image and to its wallet, Israel-based Teva Pharmaceutical Industries recently announced it will stop production of its sedative propofol, which many worry will intensify an already existing shortage of one of the most widely used anesthetics in the United States.We here at Abnormal Use previously reported on one of these two potential catalysts to the halt in production here, where we evaluated the Nevada jury's… [read post]
29 Jan 2009, 3:48 am
Amphastar Pharmaceuticals and Teva (on petition for a writ of certiorari) In a split 2008 decision, the Federal Circuit affirmed a lower court decision holding two Aventis patents unenforceable due to inequitable conduct. [read post]
10 Feb 2021, 7:12 pm
Teva Pharmaceuticals USA, Inc. [read post]
17 Aug 2010, 9:42 am
Teva Pharmaceuticals USA, Inc., C.A. [read post]
30 Nov 2012, 6:00 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
30 Nov 2012, 6:00 am
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
16 May 2019, 8:15 am
The Federal Circuit recently affirmed a district court ruling finding patent infringement after holding that Actavis LLC, Actavis South Atlantic LLC, and Teva Pharmaceuticals USA, Inc. [read post]
10 Jul 2015, 11:46 am
Cephalon, which is now owned by Teva, has agreed to pay the United States and participating states a total of $7.5 million. [read post]
28 Nov 2021, 6:58 am
The recent decision of the English High Court in Bayer v Teva [2021] EWHC 2690 (Pat) is another example in which the UK courts have found a pharmaceutical invention to be the obvious outcome of routine drug development. [read post]
29 Jun 2016, 4:13 am
The patent-in-suit concerned a new formulation of the already known pharmaceutical substance quetiapine in a sustained release comprising the active substance quetapine and a gelling agent together with one or more pharmaceutically acceptable excipients. [read post]
18 Dec 2023, 9:07 pm
Teva Pharmaceuticals USA (Fed. [read post]
